Skip to main content
Clinical Trials/NL-OMON22550
NL-OMON22550CompletedNot Applicable

Effectiveness of a two-day EMDR treatment programme for parents of MPS III patients: a randomized controlled pilot trial

Amsterdam UMC, location AMC0 sites24 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
24

Study Overview

Brief Summary

Outcomes of this study will be published in international scientific peer-reviewed journals.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • An increased score (moderately or higher) on one symptom in each cluster (B, C, D or E) or met 3 of the 4 PTSD criteria (one B symptom, one C symptom, two D symptoms and two E symptoms) measured by the PTSD Check List for DSM-5 (PCL-5) or an increased total score (>24) on the PCL-5.
  • - Being motivated for a short, intensive EMDR treatment programme.
  • - Parenting a child with MPS III under treatment by a metabolic paediatrician in het Emma Children’s Hospital/Amsterdam UMC.
  • - Having sufficient knowledge of the Dutch language to complete the assessments.
  • - Willingness to give a written informed consent in advance.

Exclusion Criteria

  • - Major interfering acute medical or psychiatric condition, such as psychosis, substance dependence or high risk for suicide.
  • - Insufficient fluency of the Dutch language.
  • - Receiving psychological (trauma) treatment by another therapist at the same time.

Investigators

Sponsor
Amsterdam UMC, location AMC

Similar Trials